Transcode Therapeutics

Newton, United States

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

Apr 2026

Post-IPO Debt

Biotechnology Health Care Oncology Therapeutics

Top Investors

National Institutes of HealthRed Cedar VenturesTRITON FUNDS LLCNational Cancer InstituteCK Life Sciences International

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Transcode Therapeutics

Who are Transcode Therapeutics's investors?

Transcode Therapeutics's investors include National Institutes of Health, Red Cedar Ventures, TRITON FUNDS LLC, National Cancer Institute, CK Life Sciences International.

Where is Transcode Therapeutics headquartered?

Transcode Therapeutics is headquartered in Newton, United States.

What does Transcode Therapeutics do?

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

What stage is Transcode Therapeutics at?

Transcode Therapeutics is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 7, 2026.

MLA

"Transcode Therapeutics — Funding & Investors." VCBacked, April 7, 2026, https://www.vcbacked.co/company/transcode-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Transcode Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/transcode-therapeutics

Wikipedia (cite web)

{{cite web |title=Transcode Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/transcode-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 7, 2026.